(Q34600691)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11952824%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

review article

1 reference

title

Pathophysiology of pruritus in atopic dermatitis: an overview (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11952824%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11952824%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Martin Steinhoff

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11952824%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

author name string

Sonja Ständer

series ordinal

1

1 reference

3 August 2017

Martin Steinhoff

series ordinal

2

1 reference

3 August 2017

1 February 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11952824%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

published in

Experimental Dermatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11952824%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11952824%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11952824%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

12-24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11952824%20AND%20SRC:MED&resulttype=core&format=json

Itching and the atopic skin

9 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

Spinothalamic lamina I neurons selectively sensitive to histamine: a central neural pathway for itch

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

Density and fine structure of peripheral nerves in various skin lesions of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

Expression and function of nerve growth factor and nerve growth factor receptor on cultured keratinocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

Identification of Candida albicans. Further work on the rapid identification of Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

Acetylcholine is an inducer of itching in patients with atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

Epidermal adrenergic signal transduction as part of the neuronal network in the human epidermis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

Biological functions of keratinocyte cholinergic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

Processing of histamine-induced itch in the human cerebral cortex: a correlation analysis with dermal reactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

Skin reactions and itch sensation induced by epicutaneous histamine application in atopic dermatitis and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

Skin-nervous system interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

Cutaneous reactions and sensations after intracutaneous injection of vasoactive intestinal polypeptide and acetylcholine in atopic eczema patients and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

Neuropeptide-like immunoreactivity in skin lesions of atopic dermatitis and psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

Skin levels of vasoactive intestinal polypeptide in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

A double-blind evaluation of topical capsaicin in pruritic psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

Treatment of prurigo nodularis with topical capsaicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

Neuropharmacological mechanisms of capsaicin and related substances

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

The control of pain in peripheral tissue by opioids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

Naloxone modulates the perception of itch in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

Recent studies of cutaneous nociception in atopic and non-atopic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

21 January 2018

Opiates, sleep and itch.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

Human keratinocytes synthesize, secrete, and degrade acetylcholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

Mast cell mediators other than histamine induce pruritus in atopic dermatitis patients: a dermal microdialysis study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

The antipruritic effect of a sedative and a non-sedative antihistamine in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

Mast cells and atopic dermatitis. Stereological quantification of mast cells in atopic dermatitis and normal human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

Immunohistochemical studies on NAP-1/IL-8 in contact eczema and atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

Detection of plasma interleukin-8 in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

Neurotrophin-4 production by human epidermal keratinocytes: increased expression in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

Immune regulation in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

CD30 expression on circulating memory CD4+ T cells as a Th2-dominated situation in patients with atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

Generation and metabolism of 5-lipoxygenase pathway leukotrienes by human eosinophils: predominant production of leukotriene C4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

Itch and atopic dermatitis: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

Skin barrier defect in atopic dermatitis: increased permeability of the stratum corneum using dimethyl sulfoxide and theophylline

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

The clinical spectrum of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

Food hypersensitivity and atopic dermatitis: pathophysiology, epidemiology, diagnosis, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

Psychological stress perturbs epidermal permeability barrier homeostasis: implications for the pathogenesis of stress-associated skin disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

Acute immobilization stress triggers skin mast cell degranulation via corticotropin releasing hormone, neurotensin, and substance P: A link to neurogenic skin disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part I, efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

Recombinant interferon gamma therapy for atopic dermatitis

21 January 2018

2 references

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

21 January 2018

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

High-potency topical corticosteroid rapidly decreases histamine-induced itch but not thermal sensation and pain in human beings

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

Doxepin affects acetylcholine induced cutaneous reactions in atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

Treatment of severe atopic dermatitis by topical immune modulation using dinitrochlorobenzene

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

Topical dinitrochlorobenzene therapy in the treatment of refractory atopic dermatitis: systemic immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

A pilot study examining the role of zileuton in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

Effects of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

Expression of interleukin-6 and its receptor in the sciatic nerve and cultured Schwann cells: relation to 18-kD fibroblast growth factor-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

Treatment of atopic dermatitis: A comparison of psychological and dermatological approaches to relapse prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

Sixty years of C-fiber recordings from animal and human skin nerves: historical notes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Specific C-receptors for itch in human skin.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Increased number of immunoreactive nerve fibers in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Cutaneous nerves in atopic dermatitis. A histological, immunohistochemical and electron microscopic study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Neuropeptides in skin from patients with atopic dermatitis: an immunohistochemical study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Overexpression of nerve growth factor in epidermis of transgenic mice causes hypertrophy of the peripheral nervous system

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

The structure of normal skin and the morphology of atopic eczema

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Parasympathetic innervation of cutaneous blood vessels by vasoactive intestinal polypeptide-immunoreactive and acetylcholinesterase-positive nerves: Histochemical and experimental study on rat lower lip

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

What exactly is "atopy"?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Acute Effects of Substance P and Calcitonin Gene-Related Peptide in Human Skin – A Microdialysis Study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Neuropeptide Y-like immunoreactivity in Langerhans cells from patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Neuropeptides in skin disease: increased VIP in eczema and psoriasis but not axillary hyperhidrosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Effects of topically applied capsaicin on moderate and severe psoriasis vulgaris

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Topical administration of capsaicin in dermatology for treatment of itching and pain

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

The capsaicin receptor: a heat-activated ion channel in the pain pathway

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Potentiation of histamine-induced itch and flare responses in human skin by the enkephalin analogue FK 33-824, ?-endorphin and morphine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Butorphanol-induced pruritus antagonized by naloxone

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

The presence of IgE on macrophages and dendritic cells infiltrating into the skin lesion of atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Pain, itch and endorphins

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Opiate and H1 antagonist effects on histamine induced pruritus and alloknesis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Raised beta-endorphin serum levels in children with atopic dermatitis and pruritus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Efficacy and safety of nalmefene in patients with severe pruritus caused by chronic urticaria and atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Keratinocyte muscarinic acetylcholine receptors: immunolocalization and partial characterization

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Acetylcholine in normal and diseased skin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Administration of acetylcholine and vasoactive intestinal polypeptide to atopic eczema patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Skin histamine levels in chronic atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Cutaneous histamine levels and histamine releasability from the skin in atopic dermatitis and hyper-IgE-syndrome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Reduced histamine reaction in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

The neurohistology and neurophysiology of the itch sensation in man

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Quantitative analysis of tryptase- and chymase-containing mast cells in atopic dermatitis and nummular eczema

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Enzyme- and immunohistochemical localization of mast cell tryptase in psoriatic skin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Mast cell tryptase and chymase are potential regulators of neurogenic inflammation in psoriatic skin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Itch and inflammation induced by intradermally injected interleukin-2 in atopic dermatitis patients and healthy subjects

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Skin testing of the pruritogenic activity of histamine and cytokines (interleukin-2 and tumour necrosis factor-alpha) at the dermal-epidermal junction

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Bradykinin potentiates the chemoresponsiveness of rat cutaneous C-fibre polymodal nociceptors to interleukin-2

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Immunohistochemical localization of interleukin-6-like immunoreactivity to peripheral nerve-like structures in normal and inflamed human skin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Role of antigen-induced cytokine release in atopic pruritus.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

The effect of azelastin hydrochloride on pruritus and leukotriene B4 in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Increased levels in vivo of mRNAs for IL-8 and macrophage inflammatory protein-1 alpha (MIP-1 alpha), but not of RANTES mRNA in peripheral blood mononuclear cells of patients with atopic dermatitis (AD)

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Systemic interferon gamma treatment in severe atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Replenishment of RANTES mRNA expression in activated eosinophils from atopic asthmatics

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Comparative studies of human eosinophil migration towards platelet-activating factor and leukotriene B4.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Preferential human eosinophil chemotactic activity of the platelet-activating factor (PAF) 1-0-hexadecyl-2-acetyl-sn-glyceryl-3-phosphocholine (AGEPC)

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Comparison of histamine release and prostaglandin E2 production of human basophils in atopic and normal individuals

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Basophil mediator release in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Atopic dermatitis: triggering factors.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

DIFFERENCES IN THE DYNAMICS OF SWEAT SECRETION IN ATOPIC CHILDREN

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

The effects of thermal stimulation on clinical and experimental itch

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Itching from wool fibres in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

The influence of mechanical vibratory stimulation and transcutaneous electrical nerve stimulation on experimental pruritus induced by histamine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Depression modulates pruritus perception: a study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticaria

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Experimental histamine pruritus. I. Influence of physical and psychological factors on threshold reactivity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

[Psychophysiologic and psychoneuroimmunologic studies in neurodermatitis. Overview and critical evaluation]

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Treatment of atopic eczema with oral mycophenolate mofetil

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Treatment of atopic dermatitis with mycophenolate mofetil

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Double-blind study of prednicarbate versus fluocortin butyl ester in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

The effects of topical doxepin on responses to histamine, substance P and prostaglandin E2 in human skin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Self-potentiating allergic contact dermatitis caused by doxepin hydrochloride cream

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Type 4 phosphodiesterase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Intradermal leukotriene B4, but not prostaglandin E2, induces itch-associated responses in mice

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Inhibition of intradental nerve excitability by leukotriene B4 and C4

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

The leukotriene antagonist zafirlukast as a therapeutic agent for atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021

Eicosanoids in skin of patients with atopic dermatitis: prostaglandin E2 and leukotriene B4 are present in biologically active concentrations

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110102.X

7 January 2021